About This Project
70% of breast cancers are estrogen receptor α (ERα)-positive. ERα is the antenna that senses the ovarian hormone estrogen (E2) and drives tumour cell proliferation and spreading. 4OH-tamoxifen and faslodex are given to patients to prevent cancer growth and spreading but they possess serious side effects. Thus, additional drugs are needed to fight breast cancer. We will explore existing drugs for the possibility of ‘reuse’ as breast cancer drugs.
Recent Lab Notes From This Project
Browse Other Projects on Experiment
Does bias about medical diagnosis link to expectations of mental health problems for infants and their parents?
If doctors think infants will have lower skill (e.g., less able to look and to smile at parents), does that...